Akt1, but not Akt2, was shown to promote breast cancer cell proliferation by upregulating cyclin D1 and S6 (a downstream target of mTORC1) in IBH-6 and T47D breast cancer cells [70]. The gene discussed is AKT2; the disease is breast carcinoma.